Aoxing Pharmaceutical (AXN) Widens Q3 Loss to 6c/Share
Get Alerts AXN Hot Sheet
Join SI Premium – FREE
Aoxing Pharmaceutical Co., Inc. (NYSE: AXN) reported Q3 EPS of ($0.06), versus ($0.01) reported last year. Revenue for the quarter came in at $1.81 million, versus $1.63 million reported last year.
For earnings history and earnings-related data on Aoxing Pharmaceutical Co., Inc. (AXN) click here.
For earnings history and earnings-related data on Aoxing Pharmaceutical Co., Inc. (AXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
- Towne Bank (TOWN) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!